Portugal, May 19 -- Portugal based LUSOPALEX - Produtos de Saude, Unipessoal Lda. has secured contract from Instituto Portugues do Sangue e da Transplantacao, IP for Blood-testing reagents Acquisition of Reagents for Defining ANTI-HLA Allosensitization in Clinical Histocompatibility from IPST IP during the years 2025 and 2026 . The value of the contract is worth 149675500 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....